Examines how FMN variants affect product profiles in NfsA, suggesting improved engineering is needed for amine generation.
Flavin mononucleotide (FMN)-dependent nitroreductases offer a mild and selective route to reduce nitroaromatic compounds, yet these typically fail to generate the corresponding amines. This incomplete transformation has been attributed to the two-electron redox potential of FMN. To test this hypothesis, the major nitroreductase NfsA from Escherichia coli was reconstituted with a series of FMN variants spanning midpoint potentials of -215 to -307 mV. Product profiles were examined with four substrates covering a range of electron affinities (nitrofurazone, 1,3-dinitrobenzene, 4-nitroacetophenone, and nitrobenzene), and all combinations of enzymes and substrates were found to yield only the hydroxylamine products. No amines were detected under any condition, and as a confirmation, 4-hydroxylaminacetophenone was shown to be inert to treatment with reduced nicotinamide adenine dinucleotide phosphate and NfsA reconstituted with a low-potential FMN variant (-295 mV). The inability of NsfA to generate amines is consequently not a function of the reducing potential. However, this is a determinant of the catalytic efficiency. The kcat for nitroacetophenone turnover decreased almost 240-fold for NfsA containing an FMN variant with an Em of -307 mV relative to that containing native FMN (-215 mV). 1,3-Dinitrobenzene experienced the smallest decrease of 52-fold in the same comparison. Redox tuning of NfsA can therefore be detrimental to catalytic efficiency and fails to generate the desired amine products. A renewed focus on active site properties is recommended for engineering new catalysts to promote nitroaromatic to arylamine conversion.
No takes yet. Share an insight, caveat, or question.
Cheema et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: